Blog

A reference to the Canadian company for the production of vaccines and veterinary medicines No. 82 in 03/02/2015.

Held general assembly of the company in the 25/02/2015 meeting to discuss the final accounts for the financial year ended 31.12.2013 and discuss the proposal to increase the company’s capital (5,400,000,000) dinars to (5,940,000,000) dinars in accordance with Article (55 / II).

And it will be the last trading session on the company’s shares at 17/02/2015.